Publications by authors named "M Alexander-Bridges"

Claim this Profile
S
Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting.
Gregory A Nichols, Shravanthi R Gandra, Chiun-Fang Chiou, Mary S Anthony, Maria Alexander-Bridges

Curr Med Res Opin· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "increasing minority participation in clinical research": a white paper from the endocrine society.
Maria Alexander-Bridges, Loretta L Doan,

J Clin Endocrinol Metab· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.
C M Cahill, G Tzivion, N Nasrin, S Ogg, J Dore, M Alexander-Bridges

J Biol Chem· April 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells.
N Nasrin, S Ogg, C M Cahill, W Biggs, S Nui, M C Alexander-Bridges

Proc Natl Acad Sci U S A· September 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene.
C Buggs, N Nasrin, A Mode, P Tollet, H F Zhao, M Alexander-Bridges

Mol Endocrinol· September 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis